Company Filing History:
2 out of 305 
1 out of 29 
Years Active: 2001-2012
Title: Innovations of Inventor Xiao Shu He
Introduction
Xiao Shu He is a notable inventor based in Branford, Connecticut, who has made significant contributions to the field of pharmaceuticals. With a total of three patents to her name, she has focused on developing compounds that target specific receptors in the human body, particularly in relation to inflammatory and immune system disorders.
Latest Patents
One of her latest patents is titled "Aryl imidazoles and related compounds as C5a receptor modulators." This invention provides packaged pharmaceutical preparations of aryl substituted imidazoles, pyrazoles, pyridizines, and related compounds. These compounds serve as ligands for C5a receptors, with preferred compounds exhibiting high affinity and neutral antagonist or inverse agonist activity. The invention also encompasses pharmaceutical compositions comprising these compounds and their use in treating various inflammatory and immune system disorders. Another patent involves "2-piperazinoalkylaminobenzoazole derivatives," which are dopamine receptor subtype specific ligands.
Career Highlights
Throughout her career, Xiao Shu He has worked with prominent companies in the pharmaceutical industry, including Neurogen Corporation and Novartis International Pharmaceutical, Ltd. Her work has contributed to advancements in drug development and therapeutic applications.
Collaborations
Xiao Shu He has collaborated with notable colleagues, including George P. Luke and George D. Maynard, enhancing her research and development efforts in the pharmaceutical sector.
Conclusion
Xiao Shu He is a distinguished inventor whose work in pharmaceutical innovations has the potential to impact the treatment of various disorders. Her patents reflect her commitment to advancing medical science and improving patient outcomes.